Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02203331 · ClinicalTrials.gov registry record · Phase 2
Bay98-7196, Dose Finding / POC Study
A Phase 2 study, sponsored by Bayer.
- Completed
- Registry status
- Phase 2
- Development phase
- 319
- Enrollment target
NCT02203331: Completed Phase 2 study, sponsored by Bayer.
NCT02203331 is a Phase 2 study that has completed, run by Bayer. The registered enrollment target is 319 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (140% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02203331, a Phase 2 study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 319 participants
- Enrollment target
Study Summary
Purpose of the study is to test efficacy and safety of BAY98-7196 intravaginal ring as a new treatment option for patients with endometriosis-associated pelvic pain
Primary Outcome
Pain intensity was assessed on 11-point (0-10) NRS by question 1. In question 1, participants were asked to rate the pain in the target area during the past 24 hours, where 0= no pain and 10= worst imaginable pain and responses were recorded in ESD. The mean pain of the 7 days with worst EAPP within a 28-day window was calculated as the sum of ESD item 1 on 7 days with worst EAPP within that 28-day window divided by 7.
Interventions
- DRUG Placebo
- DRUG Anastrozole
- DRUG Levonorgestrel
- DRUG Lupron / Leuprolide acetate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 319 participants |
| Start Date | 2014-10-16 |
| Est. Completion | 2016-10-24 |
| Phase | Phase 2 |
What the finished NCT02203331 record still lists
NCT02203331 is an interventional study that assigns participants to a tested intervention. The registered 319 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (140% higher).
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT02203331 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02203331 about?
NCT02203331 is a clinical study titled "Bay98-7196, Dose Finding / POC Study". Purpose of the study is to test efficacy and safety of BAY98-7196 intravaginal ring as a new treatment option for patients with endometriosis-associated pelvic pain
What is the current status of trial NCT02203331?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 319 participants. The study started on 2014-10-16. Estimated completion is 2016-10-24.
What interventions are being tested in trial NCT02203331?
The interventions under investigation include: Placebo (DRUG), Anastrozole (DRUG), Levonorgestrel (DRUG), Lupron / Leuprolide acetate (DRUG).
Who is sponsoring clinical trial NCT02203331?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02203331's enrollment target sits among peer trials
319 153rd of 2000 higher than 1,848 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05377996 · 319 participants · Phase 1
A Study of XMT-1660 in Participants With Solid Tumors
- NCT02763683 · 320 participants
Investigations of Dementia in Parkinson Disease
- NCT03331198 · 320 participants · Phase 1
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
- NCT03458832 · 320 participants
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI